由差异表达基因引起的血小板功能障碍是COVID-19中关键的致病机制
Xiaoyong Tan1, Xiaojun Gao2,3,4, Huanhuan Zheng5
1Department of Pharmacy, Xuanhan County People's Hospital, Dazhou, China.
Minerva cardiology and angiology
|May 28, 2024
概括
COVID-19 感染显著改变了血小板基因表达和功能,可能会影响疾病的严重程度. 本研究确定了关键基因,并讨论了2019年新型冠状病毒病患者的血小板功能障碍并发症的管理方法.
科学领域:
- 血液学 血液学 血液学
- 病毒学 病毒学
- 分子生物学分子生物学
背景情况:
- 由SARS-CoV-2引起的COVID-19大流行,对全球健康构成了重大挑战.
- 患有COVID-19的患者经常表现出血液学异常,特别是血小板功能障碍,这与疾病严重程度和死亡率有关.
- SARS-CoV-2 感染会改变血小板基因表达和功能,有证据表明血小板可能会独立于 ACE2 内化病毒mRNA.
研究的目的:
- 审查COVID-19,血小板和SARS-CoV-2引起的循环损伤之间的关系.
- 分析SARS-CoV-2感染后血小板中差异表达的mRNA,并确定关键基因.
- 探索SARS-CoV-2对血小板转录异常和功能障碍的影响,并讨论相关并发症的治疗策略.
主要方法:
- 关于COVID-19,血小板功能和循环系统损伤的文献综述.
- 在SARS-CoV-2感染后血小板中差异表达mRNA的生物信息分析.
- 鉴定了八个枢纽基因 (NLRP3,MT-CO1,CD86,ICAM1,MT-CYB,CASP8,CXCL8,CXCR4) 的发现.
- 基于已识别的枢纽基因,探索SARS-CoV-2对血小板转录组学和功能的影响.
主要成果:
- 在SARS-CoV-2感染个体中证实了血小板基因表达特征的显著变化.
- 确定了8个枢纽基因,这些基因在调解SARS-CoV-2对血小板的影响方面至关重要.
- SARS-CoV-2 感染导致血小板转录异常和功能障碍,与疾病严重程度有关.
结论:
- 血小板功能障碍是COVID-19病变和患者结果的关键因素.
- 了解已识别的枢纽基因为SARS-CoV-2引起的血小板异常提供了洞察力.
- 对血小板功能障碍并发症的管理策略对于COVID-19患者的护理和康复至关重要.
相关概念视频
01:18Structure and Function of Platelets
1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
01:22Formation of the Platelet Plug
5.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.8K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
681
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
681
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
521
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
521
01:24Disorders of Hemostasis
845
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
845
01:38Inflammation
53.4K
Overview
53.4K